Specifically, our group identified that participants with IBS who were homozygous for the catechol-O-methyltransferase (COMT) rs4680 met (met/met) had the greatest improvement across treatment arms as measured by the IBS-SSS. This evidence concerns the gene COMT and irritable bowel syndrome.